It has been assumed that β-AR antagonists (β-blockers) have a direct favorable ... The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353(9146), 9–13 (1999).

Heart failure with reduced ejection fraction (HFrEF) represents a significant global health burden, affecting over 64 million individuals and resulting in substantial morbidity and mortality, ...

However, β blockers do not all share the same clinical outcomes with respect to efficacy or safety in many of these conditions. This is especially true in HF, where differences in reverse ...

Drinking beetroot juice in the morning without food may improve the absorption of nitrates that can help lower blood pressure ...

It can be highly life-threatening. Metoprolol is a prescription beta-blocker used to treat various heart-related conditions. It relaxes blood vessels by acting on specific receptors to enhance blood ...

Trial registration number NCT01970748. According to the Baveno VII consensus, treatment with non-selective beta-blockers (NSBBs) should be used to prevent decompensation in patients with clinically ...